zeus semaglutide Health Rounds: Novo Nordisk's may help some with type 1 diabetes Sermorelin Peptide Therapy - ZEUS

Here are the average weight loss results based on the dose and timeline: 1 mg: 7.2% in 24 weeks and 8.7% in 48 weeks 4 mg: 12.9% in 24 weeks and 16.3% in 48 weeks 8 mg: 17.3% in 24 weeks and 23.9% in 48 weeks 12 mg: 17.5% in 24 weeks and 24.2% in 48 weeks Placebo: 1.6% in 24 weeks and 2.1% in 48 weeks The retatrutide clinical trials are still ongoing, with a phase IV planned after the current phase III

Molecular analyses also demonstrated favorable modulation of adipogenesis-related transcription factors and key lipogenesis genes

Cochrane Database Syst Rev 2014;2014(2):Cd009122

Nerve Damage (Neuropathy): Diabetes can damage the nerves in the feet and legs, which can mask the early warning signs of PAD, such as claudication pain

7 May 2026

En Vogue IV Therapy & Wellness Center provides medical weight loss, including oral semaglutide treatment